Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
By Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini
• Context: Over centuries, the management of deep vein thrombosis (DVT) has evolved from empirical bloodletting to the precision of direct oral anticoagulants (DOACs).
• Overview: This historical review traces how DOACs revolutionized therapy—simplifying treatment, redefining duration and intensity, and reshaping clinical guidelines.
• Reflection: Despite progress, the “philosopher’s stone” of anticoagulation—perfect safety without loss of efficacy—remains elusive. Novel FXI/XIa inhibitors and AI-guided individualized therapy may herald the next transformation in DVT care.”
Read the full article in JTH.
Article: The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
Authors: Jean Philippe Galanaud, Jean Pierre Laroch, Marc Righini
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda